Atraxin en es it fr

Atraxin Brand names, Atraxin Analogs

Atraxin Brand Names Mixture

  • No information avaliable

Atraxin Chemical_Formula


Atraxin RX_link

No information avaliable

Atraxin fda sheet

Atraxin msds (material safety sheet)

Atraxin Synthesis Reference

No information avaliable

Atraxin Molecular Weight

309.469 g/mol

Atraxin Melting Point

< 25 oC

Atraxin H2O Solubility

Soluble as HCl salt

Atraxin State


Atraxin LogP


Atraxin Dosage Forms

Tablets (oral, 1 mg)

Atraxin Indication

Used for the symptomatic treatment of parkinsonism.

Atraxin Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Atraxin Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Atraxin side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Atraxin Patient Information

Atraxin Organisms Affected

Humans and other mammals